Join Cedars-Sinai Cancer during a transformational period of growth and join us in our mission to solve unmet needs in cancer by studying populations we are uniquely positioned to address, through serving the diverse population of Los Angeles, and then translating discoveries to global impacts. We are seeking a Hematologist/Oncologist to join the Division of Hematology and Cellular Therapy with a focus on the development of translational research and clinical trials for the treatment of multiple myeloma and plasma cell disorders.
The selected candidate will have programmatic, inpatient and outpatient clinical, administrative, academic and research responsibilities in the program and will be supported by all necessary advanced practice providers, research and administrative staff to excel in their role. The hematologist/oncologist will collaborate with multi-disciplinary teams across Cedars-Sinai Cancer. The selected candidate will also participate in educational, research, and community outreach and engagement activities that are in alignment with departmental/divisional and Cedars-Sinai Cancer priorities.
The successful candidate has the following:
- A track record of, and dedication to, excellence in patient care with three years of relevant experience and a track record as a published author or co-author of peer-reviewed articles.
- Interest and demonstrated experience or training in clinical or basic research.
- Excellent communication skills, with the ability to collaborate effectively with a diverse group of colleagues, organizations and leaders.
- Eligible for appointment to the Assistant Professor rank in the Cedars-Sinai Medical Center Professoriate.
- Medical Degree from an accredited medical school.
- Board eligibility/certification in Internal Medicine and in the subspecialty of Hematology/Oncology.
- Unrestricted California license as a Physician.
Interested candidates should apply by uploading their CV and a cover letter addressed to John P. Chute, MD, Linda Ostrowski Chair in Hematology/Oncology and Director, Division of Hematology and Cellular Therapy, CSMC at .
At Cedars-Sinai, we are caretakers and innovators committed to the pursuit of equitable healthcare. Our commitment to diversity goes beyond demographics or checking boxes. Our people must reflect the diverse identities, experiences and geographies of the communities and patients we serve.
About Cedars-Sinai Cancer
At Cedars-Sinai Cancer, we offer state-of-the-art treatments, experimental therapies, next-generation research and cutting-edge clinical trials for over 60 types of cancer at more than 10 locations throughout Greater Los Angeles. Patients turn to us because they know our progress is their progress, and our strides forward are their success.
About Cedars-Sinai
Ranked #1 in California and on the “Best Hospitals” Honor Roll for nine years in a row, we are a national leader in providing high-quality, patient-centered healthcare that encompasses primary care as well as specialized medicine and conducting research that leads to lifesaving discoveries and innovations.
Academic Research
Along with caring for patients, Cedars-Sinai is a hub for biomedical research and a top 10 academic medical center for NIH funding with over $230M in extramural research grant funding. As the largest academic medical center in the western United States, Cedars-Sinai is also training the next generation of physicians, researchers, and allied health professionals.
Our compensation philosophy
We offer competitive total compensation that includes pay, benefits, and other incentive programs for our employees. The total pay range shown takes into account the wide range of factors that are considered in making compensation decisions including knowledge/skills; relevant experience and training; education/certifications/licensure; and other business and organizational factors. This total pay range includes any incentive payments that may be applicable to this role. We also offer a comprehensive faculty benefits package.
Pay Range: $398,537 - $531,851 total cash compensation.